Gilead Sciences (GILD) EV to EBIT (2009 - 2026)
Gilead Sciences' (GILD) EV to EBIT came in at 15.95 for Q1 2026, down 0.3% from 15.99 a year earlier but up 10.5% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) EV to EBIT (2009 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, EV to EBIT at Gilead Sciences was 14.00, up 1.2% year-over-year; for FY2025, it came in at 14.43, down 77.2% from FY2024.
- In prior years, Gilead Sciences' EV to EBIT was 63.19 in FY2024 (+413.5%), 12.31 in FY2023 (-10.4%), 13.73 in FY2022 (+61.1%) and 8.52 in FY2021 (-47.2%).
- Quarterly EV to EBIT has run from a low of 7.04 in Q3 2021 to a high of 120.86 in Q3 2024 over five years.
- On a year-over-year basis, EV to EBIT has declined in each of the last five quarters, with growth averaging 47.5% over the last seven quarters.
- The strongest year-over-year quarter for EV to EBIT in the past five years was Q4 2024, with growth of 413.5%; the weakest was Q3 2025, with a decline of 89.7%.
- According to Business Quant data, EV to EBIT for the three prior quarters was 14.43 (Q4 2025), 12.43 (Q3 2025) and 16.45 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 15.95 |
| Dec 31, 2025 | 14.43 |
| Sep 30, 2025 | 12.43 |
| Jun 30, 2025 | 16.45 |
| Mar 31, 2025 | 15.99 |
| Dec 31, 2024 | 63.19 |
| Sep 30, 2024 | 120.86 |
| Jun 30, 2024 | 32.32 |
| Mar 31, 2024 | 54.80 |
| Dec 31, 2023 | 12.31 |
| Sep 30, 2023 | 10.47 |
| Jun 30, 2023 | 10.55 |
| Mar 31, 2023 | 11.05 |
| Dec 31, 2022 | 13.73 |
| Sep 30, 2022 | 11.94 |
| Jun 30, 2022 | 10.25 |
| Mar 31, 2022 | 9.59 |
| Dec 31, 2021 | 8.52 |
| Sep 30, 2021 | 7.04 |
| Jun 30, 2021 | 8.16 |
API Access
Gilead Sciences EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();